SEC Form 4 · accession 0001730463-26-000097
Autolus Therapeutics plc · AUTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cynthia M Butitta
Director
Period of report
Jun 29, 2026
Accepted (ET)
Jul 1, 2026 · 4:11 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001730463
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Share UnitsF1,F2 | — | Jun 29, 2026 | A | 31,667 | A | — | — | American Depositary Shares | 31,667 | 31,667 | D |
| Share Option (Right to Buy)F3 | $1.61 | Jun 29, 2026 | A | 47,500 | A | — | Jun 29, 2036 | American Depositary Shares | 47,500 | 47,500 | D |
Explanation of responses
- F1Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.
- F2The RSUs vest in one installment on June 29, 2027.
- F3Share options vest in twelve equal monthly installments commencing on July 29, 2026.